Literature DB >> 5789770

The monoamine oxidase catalyzed degradation of phenelzine-l-14C, an irreversible inhibitor of monoamine oxidase--II. Studies in vivo.

B V Clineschmidt, A Horita.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5789770     DOI: 10.1016/0006-2952(69)90105-1

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


× No keyword cloud information.
  13 in total

Review 1.  Insights into the mechanisms of action of the MAO inhibitors phenelzine and tranylcypromine: a review.

Authors:  G B Baker; R T Coutts; K F McKenna; R L Sherry-McKenna
Journal:  J Psychiatry Neurosci       Date:  1992-11       Impact factor: 6.186

2.  The myth of phenelzine acetylation.

Authors:  E F Marshall
Journal:  Br Med J       Date:  1976-10-02

3.  The reaction of monoamine oxidase with phenethylhydrazine.

Authors:  K F Tipton
Journal:  Biochem J       Date:  1971-02       Impact factor: 3.857

4.  Phenelzine causes an increase in brain ornithine that is prevented by prior monoamine oxidase inhibition.

Authors:  Erin M MacKenzie; Suzanne L Grant; Glen B Baker; Paul L Wood
Journal:  Neurochem Res       Date:  2007-08-31       Impact factor: 3.996

5.  Inhibition of monoamine oxidase by substituted hydrazines.

Authors:  K F Tipton
Journal:  Biochem J       Date:  1972-07       Impact factor: 3.857

6.  The kinetics of phenethylhydrazine oxidation by monoamine oxidase.

Authors:  K F Tipton; I P Spires
Journal:  Biochem J       Date:  1971-11       Impact factor: 3.857

7.  Purification and properties of the trimethylamine dehydrogenase of bacterium 4B6.

Authors:  J Colby; L J Zatman
Journal:  Biochem J       Date:  1974-12       Impact factor: 3.857

8.  Urinary excretion of bioactive amines and their metabolites in psychiatric patients receiving phenelzine.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Neurochem Res       Date:  1993-09       Impact factor: 3.996

9.  N2-acetylphenelzine: effects on rat brain GABA, alanine and biogenic amines.

Authors:  K F McKenna; G B Baker; R T Coutts
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1991-05       Impact factor: 3.000

Review 10.  Metabolism of monoamine oxidase inhibitors.

Authors:  G B Baker; L J Urichuk; K F McKenna; S H Kennedy
Journal:  Cell Mol Neurobiol       Date:  1999-06       Impact factor: 5.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.